Combining biology and deep tech to cure and prevent disease
scientificamerican.com
news
2022-05-29 05:00:00

Bayer is combining advances in cell biology and synthetic biology with applied engineering to develop new ways to prevent disease, detect it early or address the root cause. To keep the global company nimble and to drive further innovation, Bayer directs 60% of its translational and clinical research funding into partnerships with small biotech and digital health startups. Through investments, joint research, lab development, grants, marketing, and mentorship, Bayer is pursuing the ultimate goal of bringing the right treatment to the right patient at the right time.
